Saturday, October 4, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

Novel epigenic editor, CHARM, enables brain-wide prion protein silencing

June 27, 2024
in Medicine
Reading Time: 3 mins read
0
Novel epigenic editor, CHARM, enables brain-wide prion protein silencing
68
SHARES
620
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a new study in mice, researchers introduce “CHARM,” a compact and versatile epigenetic editor that can be used to silence prion protein throughout the brain. The tool provides a path towards an effective first-line treatment for patients with deadly prion disease as well as other neurodegenerative diseases caused by the toxic buildup of unwanted proteins. Prion disease – a suite of devastating neurodegenerative disorders that result in rapid-onset dementia and death – is caused by misfolding of the prion protein, PrP, to form toxic aggregates that result in neuronal death. Previous research in mice has shown that removing PrP from neurons can halt prion disease and reverse symptoms, indicating that strategies aimed at reducing PrP expression may represent a viable therapeutic approach even after the onset of symptoms. However, long-term and reversible silencing of PrP-expressing genes using current approaches, such as CRISPRoff, remains a challenge, necessitating the development of a more compact, potent, and safe epigenetic tool. To address this need, Edwin Neumann and colleagues developed a compact and programmable epigenetic silencer called CHARM (Coupled Histone tail for Autoinhibition Release of Methyltransferase), which is capable of silencing targeted genes with high specificity through programmable DNA methylation. The approach, which does not require DNA sequence edits, offers a potentially less cytotoxic alternative to genome-editing techniques that disrupt coding regions or splice sites. Neumann et al. show that CHARM platform can efficiently shut off the prion gene in most neurons throughout the entire mouse brain when delivered systemically by an adeno-associated virus (AAV) without altering the underlying DNA sequence. According to the findings, the approach resulted in more than 80% brain-wide knockdown of PrP expression, greatly exceeding the currently recognized minimal knockdown required for therapeutic effects. Moreover, the authors demonstrate the ability to create self-silencing CHARM editors that turn themselves off after silencing target genes, thereby avoiding potential toxicity and other adverse effects from chronic expression in neurons. “With the development of CHARMs, Neumann et al. have introduced a potent and safe editing technology for gene silencing via AAV delivery into otherwise difficult-to-target organs, such as the brain,” write Madelynn Whittaker and Kiran Musunuru in a related Perspective.

In a new study in mice, researchers introduce “CHARM,” a compact and versatile epigenetic editor that can be used to silence prion protein throughout the brain. The tool provides a path towards an effective first-line treatment for patients with deadly prion disease as well as other neurodegenerative diseases caused by the toxic buildup of unwanted proteins. Prion disease – a suite of devastating neurodegenerative disorders that result in rapid-onset dementia and death – is caused by misfolding of the prion protein, PrP, to form toxic aggregates that result in neuronal death. Previous research in mice has shown that removing PrP from neurons can halt prion disease and reverse symptoms, indicating that strategies aimed at reducing PrP expression may represent a viable therapeutic approach even after the onset of symptoms. However, long-term and reversible silencing of PrP-expressing genes using current approaches, such as CRISPRoff, remains a challenge, necessitating the development of a more compact, potent, and safe epigenetic tool. To address this need, Edwin Neumann and colleagues developed a compact and programmable epigenetic silencer called CHARM (Coupled Histone tail for Autoinhibition Release of Methyltransferase), which is capable of silencing targeted genes with high specificity through programmable DNA methylation. The approach, which does not require DNA sequence edits, offers a potentially less cytotoxic alternative to genome-editing techniques that disrupt coding regions or splice sites. Neumann et al. show that CHARM platform can efficiently shut off the prion gene in most neurons throughout the entire mouse brain when delivered systemically by an adeno-associated virus (AAV) without altering the underlying DNA sequence. According to the findings, the approach resulted in more than 80% brain-wide knockdown of PrP expression, greatly exceeding the currently recognized minimal knockdown required for therapeutic effects. Moreover, the authors demonstrate the ability to create self-silencing CHARM editors that turn themselves off after silencing target genes, thereby avoiding potential toxicity and other adverse effects from chronic expression in neurons. “With the development of CHARMs, Neumann et al. have introduced a potent and safe editing technology for gene silencing via AAV delivery into otherwise difficult-to-target organs, such as the brain,” write Madelynn Whittaker and Kiran Musunuru in a related Perspective.



Journal

Science

DOI

10.1126/science.ado7082

Article Title

Brain-wide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor

Article Publication Date

28-Jun-2024

Share27Tweet17
Previous Post

How does the human brain switch between survival tasks?

Next Post

Researchers create the first comprehensive characterization of the extraordinary thermoelectric properties of cadmium arsenide thin films

Related Posts

blank
Medicine

αCGRP Deficiency Worsens Lung Fibrosis via Cell Aging

October 4, 2025
blank
Medicine

Key Skills for New ICU Nurses in Iran

October 4, 2025
blank
Medicine

Acylation Shapes Immunotherapy Success in Liver Cancer

October 4, 2025
blank
Medicine

Herbal Remedies: Effectiveness for Type 2 Diabetes Control

October 4, 2025
blank
Medicine

Exploring Risk Factors for Greater Trochanteric Growth

October 4, 2025
blank
Medicine

MicroRNA Signatures Reveal Cancer Risk in Kidney Transplants

October 4, 2025
Next Post
Thermoelectric Test Device

Researchers create the first comprehensive characterization of the extraordinary thermoelectric properties of cadmium arsenide thin films

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27562 shares
    Share 11022 Tweet 6889
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    971 shares
    Share 388 Tweet 243
  • Bee body mass, pathogens and local climate influence heat tolerance

    646 shares
    Share 258 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    513 shares
    Share 205 Tweet 128
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    478 shares
    Share 191 Tweet 120
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • α-L-Fucosidase Isoenzymes: New Glioma Prognostic Markers
  • Inflammatory Markers Shape EGFR-Mutant Lung Cancer
  • Coal Seam Permeability Changes After Fracture Unveiled
  • Liquid Scintillator: Detecting Neutrons with Precision

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.

Join 5,186 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine